Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21238310 | 0.83 | KDM4E (0.44) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL8818379 | 0.82 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL24415499 | 0.80 | MMP2 (0.49) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL1437509 | 0.79 | KDM4E (0.44) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL18626491 | 0.79 | ALOX15 (0.47) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL20534000 | 0.79 | KDM4E (0.45) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL7997265 | 0.79 | KDM4E (0.55) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL5032446 | 0.77 | KDM4E (0.42) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL12408070 | 0.77 | KDM6B (0.44) | ALDH1A1MEN1KMT2ALMNAKDM4E | |
| SCHEMBL20970388 | 0.77 | PLG (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324814-A | Extractant for enriching metal ions and preparation method and application thereof | 山东共聚有机硅技术研究院有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-113817164-B | Hypoxic sensitive drug carrier polymer and preparation method and application thereof | 北京化工大学 | 2022-11-29 | — | — | CN | claimed |
| CN-113817164-A | Hypoxic sensitive drug carrier polymer and preparation method and application thereof | 北京化工大学 | 2021-12-21 | — | — | CN | claimed |
| WO-2025151517-A1 | THIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS ASSOCIATED WITH MISSFOLDING OF ALPHA-SYNUCLEIN PROTEIN | WAVEBREAK THERAPEUTICS LIMITED (US) | 2025-07-17 | — | — | WO | disclosed |
| CN-118955393-A | 2, 4-Dinitrophenoxy compound and preparation method thereof | 江南大学 | 2024-11-15 | — | — | CN | disclosed |
| CN-118324814-A | Extractant for enriching metal ions and preparation method and application thereof | 山东共聚有机硅技术研究院有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117756848-A | TH-302 derivative and preparation method thereof | 常州大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-113831337-B | GLP-1 receptor agonist, and pharmaceutical composition and use thereof | 广州市恒诺康医药科技有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-113817164-B | Hypoxic sensitive drug carrier polymer and preparation method and application thereof | 北京化工大学 | 2022-11-29 | — | — | CN | disclosed |
| CN-113831337-A | GLP-1 receptor agonist, and pharmaceutical composition and use thereof | 广州市恒诺康医药科技有限公司 | 2021-12-24 | — | — | CN | disclosed |
| CN-113817164-A | Hypoxic sensitive drug carrier polymer and preparation method and application thereof | 北京化工大学 | 2021-12-21 | — | — | CN | disclosed |
| WO-2012007409-A1 | N-SUBSTITUTED PYRROLIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 2012-01-19 | — | — | WO | disclosed |
| US-20120010235-A1 | N-SUBSTITUTED PYRROLIDINES | CHU XIN-JIE (US) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010235-A1 | N-SUBSTITUTED PYRROLIDINES | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PKD1, TP53 | ALDH1A1 799/4885MEN1 966/4885KMT2A 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.